Aspira Women’s Health ( (AWHL) ) has released a notification of late filing.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aspira Women’s Health Inc. has filed a Form 12b-25, notifying investors of a delayed Form 10-K (Yearly Report) for the financial year ended December 31, 2025. The company, based in Austin, Texas, is seeking a brief extension for its annual filing rather than missing the report entirely.
Management explains that the delay stems from needing additional time to complete the accounting and disclosures related to its tax provision for the 2025 fiscal year. The company does not cite any auditor change, internal control breakdown, or special committee review, suggesting the issue is confined to the complexity and finalization of its tax calculations.
Aspira Women’s Health Inc. states that it expects to file the Form 10-K (Yearly Report) within the allowed 15-calendar-day extension window granted under SEC rules. For investors, this signals a relatively short delay, with the company indicating that the late filing should be resolved within the standard grace period.
The company also indicates that it does not anticipate any significant change in results of operations versus the prior year to be reflected in the upcoming earnings statements. As with all such notifications, these are forward-looking statements and remain subject to final audit and completion of the tax-related accounting work.
Aspira Women’s Health Inc. confirms that all other required SEC periodic reports over the last 12 months have been filed on time, underscoring its broader compliance record. The notification is signed by Chief Financial Officer Brian Hungerford, signaling executive-level oversight of the delay and the company’s ongoing effort to complete the Form 10-K (Yearly Report) promptly.
The most recent analyst rating on (AWHL) stock is a Hold with a $0.44 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.
Spark’s Take on AWHL Stock
According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.
The score is held down primarily by weak financial health (negative equity, ongoing losses, and negative operating cash flow). Technicals are comparatively stronger with an established uptrend, but overbought signals temper the setup. Corporate events are broadly positive yet partly offset by dilution risk, while valuation remains constrained by unprofitability and no dividend.
To see Spark’s full report on AWHL stock, click here.
More about Aspira Women’s Health
Average Trading Volume: 50,585
Technical Sentiment Signal: Strong Sell
Current Market Cap: $15.44M
For a thorough assessment of AWHL stock, go to TipRanks’ Stock Analysis page.